Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMA6JME)

Drug Name

RTA 901 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Diabetic neuropathy	8C0Z	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Heat shock protein 90 (HSP90)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
RNS-60	DMDNRU1	Asthma	CA23	Phase 2	[3]
LAM-003	DMQHWMJ	Acute myeloid leukaemia	2A60	Phase 1	[4]
ADX-1612	DM86WI0	Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 1	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT02666963) A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Reata Pharmaceuticals.
3	Clinical pipeline report, company report or official report of Revalesio.
4	LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML. Blood Adv. 2019 Nov 26;3(22):3661-3673.
5	Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice. Int J Mol Sci. 2023 Mar 6;24(5):5014.